196 related articles for article (PubMed ID: 21397094)
21. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
[TBL] [Abstract][Full Text] [Related]
22. Bacterial vaginosis among a group of married Jordanian women: occurrence and laboratory diagnosis.
Abu Shaqra QM
Cytobios; 2001; 105(408):35-43. PubMed ID: 11368266
[TBL] [Abstract][Full Text] [Related]
23. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
Jensen JT; Nelson AL; Costales AC
Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
[TBL] [Abstract][Full Text] [Related]
24. Algorithm for nonvisible strings of levonorgestrel intrauterine system.
Vilos GA; Di Cecco R; Marks J
J Minim Invasive Gynecol; 2010; 17(6):805-6. PubMed ID: 20955995
[TBL] [Abstract][Full Text] [Related]
25. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy during the use of levonorgestrel intrauterine system.
Backman T; Rauramo I; Huhtala S; Koskenvuo M
Am J Obstet Gynecol; 2004 Jan; 190(1):50-4. PubMed ID: 14749634
[TBL] [Abstract][Full Text] [Related]
27. Cervical cytology associated with levonorgestrel contraception.
Misra JS; Engineer AD; Tandon P
Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
[TBL] [Abstract][Full Text] [Related]
28. Progestin-releasing intrauterine systems and leiomyoma.
Kaunitz AM
Contraception; 2007 Jun; 75(6 Suppl):S130-3. PubMed ID: 17531604
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.
Bahamondes MV; Monteiro I; Castro S; Espejo-Arce X; Bahamondes L
Hum Reprod; 2010 May; 25(5):1158-64. PubMed ID: 20185512
[TBL] [Abstract][Full Text] [Related]
30. [Abdominal migration of a levonorgestrel-releasing intrauterine device. Case report and review of the literature].
Pont M; Lantheaume S
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):179-81. PubMed ID: 19303222
[TBL] [Abstract][Full Text] [Related]
31. Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A.
Godfrey EM; Memmel LM; Neustadt A; Shah M; Nicosia A; Moorthie M; Gilliam M
Contraception; 2010 Feb; 81(2):123-7. PubMed ID: 20103449
[TBL] [Abstract][Full Text] [Related]
32. Symptomatic candidiasis: Using self sampled vaginal smears to establish the presence of Candida, lactobacilli, and Gardnerella vaginalis.
Engberts MK; Boon ME; van Haaften M; Heintz AP
Diagn Cytopathol; 2007 Oct; 35(10):635-9. PubMed ID: 17854078
[TBL] [Abstract][Full Text] [Related]
33. Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain.
Lete I; Cristóbal I; Febrer L; Crespo C; Arbat A; Hernández FJ; Brosa M
Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):71-80. PubMed ID: 20951492
[TBL] [Abstract][Full Text] [Related]
34. The levonorgestrel intrauterine system in nulliparous women.
Prager S; Darney PD
Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
[TBL] [Abstract][Full Text] [Related]
35. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
Lehtovirta P; Paavonen J; Heikinheimo O
Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
[TBL] [Abstract][Full Text] [Related]
36. The levonorgestrel intrauterine system: the benefits of reduced bleeding.
Cameron IT
Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():27-32. PubMed ID: 11336431
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception.
Tariq N; Ayub R; Jaffery T; Rahim F; Naseem F; Kamal M
J Coll Physicians Surg Pak; 2011 Apr; 21(4):210-3. PubMed ID: 21453616
[TBL] [Abstract][Full Text] [Related]
38. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
39. The levonorgestrel intrauterine system is an effective treatment in selected obese women with abnormal uterine bleeding.
Vilos GA; Marks J; Tureanu V; Abu-Rafea B; Vilos AG
J Minim Invasive Gynecol; 2011; 18(1):75-80. PubMed ID: 21195957
[TBL] [Abstract][Full Text] [Related]
40. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
Neven P; Amant F; Poppe W; Van den Broecke R
Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
